Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

Neisseria gonorrhoeae

  • Antimicrobial Resistance of <span class="named-content genus-species" id="named-content-1">Neisseria gonorrhoeae</span> Isolates from High-Risk Men in Johannesburg, South Africa
    Epidemiology and Surveillance
    Antimicrobial Resistance of Neisseria gonorrhoeae Isolates from High-Risk Men in Johannesburg, South Africa

    Neisseria gonorrhoeae antimicrobial drug resistance has emerged worldwide; however, the situation in sub-Saharan Africa is not well documented. We investigated the molecular epidemiology and occurrence of antimicrobial resistance in Neisseria gonorrhoeae infections in two core transmission groups of...

    Liteboho D. Maduna, Marleen M. Kock, Brian M. J. W. van der Veer, Oscar Radebe, James McIntyre, Lieke B. van Alphen, Remco P. H. Peters
  • Open Access
    Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a <span class="named-content genus-species" id="named-content-1">Neisseria gonorrhoeae</span> Hollow-Fiber <em>In Vitro</em> Infection Model
    Mechanisms of Resistance
    Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber In Vitro Infection Model

    Multidrug-resistant Neisseria gonorrhoeae has emerged as a threat to global health. The relationship between gepotidacin exposure and prevention of on-therapy amplification of drug-resistant N. gonorrhoeae was examined using a 7-day hollow-fiber in vitro infection model. The study design...

    Brian D. VanScoy, Nicole E. Scangarella-Oman, Steven Fikes, Sharon Min, Jianzhong Huang, Karen Ingraham, Sujata M. Bhavnani, Haley Conde, Paul G. Ambrose
  • Genomic Analysis Reveals Antibiotic-Susceptible Clones and Emerging Resistance in <span class="named-content genus-species" id="named-content-1">Neisseria gonorrhoeae</span> in Saskatchewan, Canada
    Epidemiology and Surveillance
    Genomic Analysis Reveals Antibiotic-Susceptible Clones and Emerging Resistance in Neisseria gonorrhoeae in Saskatchewan, Canada

    Whole-genome sequencing was used to identify mutations in antibiotic resistance-conferring genes to compare susceptibility predictions with MICs and to ascertain strain types in 99 isolates of Neisseria gonorrhoeae. Genotypes associated with susceptibility, as well as MIC creep or emerging resistance, were noted. Phylogenomic analysis revealed three distinctive clades...

    Nidhi R. Parmar, Reema Singh, Irene Martin, Sumudu R. Perera, Walter Demczuk, Anthony Kusalik, Jessica Minion, Jo-Anne R. Dillon
  • Genomic Characterization of <span class="named-content genus-species" id="named-content-1">Neisseria gonorrhoeae</span> Strains from 2016 U.S. Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin
    Epidemiology and Surveillance
    Genomic Characterization of Neisseria gonorrhoeae Strains from 2016 U.S. Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin

    In 2016, the proportion of Neisseria gonorrhoeae isolates with reduced susceptibility to azithromycin rose to 3.6%. A phylogenetic analysis of 334 N. gonorrhoeae isolates collected in 2016 revealed a single, geographically diverse lineage of isolates with MICs of 2 to 16 μg/ml that carried a mosaic-...

    Matthew W. Schmerer, A. Jeanine Abrams, Sandra Seby, Jesse C. Thomas, John Cartee, Sean Lucking, Eshaw Vidyaprakash, Cau D. Pham, Samera Sharpe, Kevin Pettus, Sancta B. St. Cyr, Elizabeth A. Torrone, Ellen N. Kersh, Antimicrobial-Resistant Neisseria gonorrhoeae Working Group, Kim M. Gernert, Antimicrobial-Resistant Neisseria gonorrhoeae Working Group
  • Equations To Predict Antimicrobial MICs in <span class="named-content genus-species" id="named-content-1">Neisseria gonorrhoeae</span> Using Molecular Antimicrobial Resistance Determinants
    Mechanisms of Resistance
    Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants

    The emergence of Neisseria gonorrhoeae strains that are resistant to azithromycin and extended-spectrum cephalosporins represents a public health threat, that of untreatable gonorrhea infections. Multivariate regression modeling was used to determine the contributions of molecular antimicrobial resistance determinants to the overall antimicrobial MICs for ceftriaxone...

    Walter Demczuk, Irene Martin, Pam Sawatzky, Vanessa Allen, Brigitte Lefebvre, Linda Hoang, Prenilla Naidu, Jessica Minion, Paul VanCaeseele, David Haldane, David W. Eyre, Michael R. Mulvey
  • A Loop-Mediated Isothermal Amplification Assay Targeting <span class="named-content genus-species" id="named-content-1">Neisseria gonorrhoeae</span> <em>penA</em>-60.001
    Mechanisms of Resistance
    A Loop-Mediated Isothermal Amplification Assay Targeting Neisseria gonorrhoeae penA-60.001

    Ceftriaxone (CRO) is widely used as the first-line treatment for gonococcal infections. However, CRO-resistant Neisseria gonorrhoeae strains carrying mosaic penA-60.001 have emerged recently and disseminated worldwide. To meet the urgent need to detect these strains, we report here a loop-mediated isothermal amplification (LAMP) assay system that targets...

    Ken Shimuta, Shu-ichi Nakayama, Hideyuki Takahashi, Makoto Ohnishi
  • Repurposing Salicylamide for Combating Multidrug-Resistant <span class="named-content genus-species" id="named-content-1">Neisseria gonorrhoeae</span>
    Experimental Therapeutics
    Repurposing Salicylamide for Combating Multidrug-Resistant Neisseria gonorrhoeae

    The U.S. Centers for Disease Control and Prevention (CDC) lists Neisseria gonorrhoeae as one of the most urgent antibiotic-resistant threats in the United States. This is due to the emergence of clinical isolates that have developed resistance to nearly every antibiotic used to treat gonorrhea and highlights the critical need to find new therapeutics.

    ...
    Marwa Alhashimi, Abdelrahman Mayhoub, Mohamed N. Seleem
  • Open Access
    Trends and Risk Factors for Antimicrobial-Resistant <em>Neisseria gonorrhoeae</em>, Melbourne, Australia, 2007 to 2018
    Editor's Pick Epidemiology and Surveillance
    Trends and Risk Factors for Antimicrobial-Resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 to 2018

    Antimicrobial resistance (AMR) in Neisseria gonorrhoeae is a major public health problem. Traditionally, AMR surveillance programs for N. gonorrhoeae have focused mainly on laboratory data to describe the prevalence and trends of resistance. However, integrating individual-level risk factors (e.g.,...

    Deborah A. Williamson, Christopher K. Fairley, Benjamin P. Howden, Marcus Y. Chen, Kerrie Stevens, Vesna De Petra, Ian Denham, Eric P. F. Chow
  • Emergence and Spread of <span class="named-content genus-species" id="named-content-1">Neisseria gonorrhoeae</span> Strains with High-Level Resistance to Azithromycin in Taiwan from 2001 to 2018
    Mechanisms of Resistance
    Emergence and Spread of Neisseria gonorrhoeae Strains with High-Level Resistance to Azithromycin in Taiwan from 2001 to 2018

    A total of 598 Neisseria gonorrhoeae isolates obtained from patients in Taiwan from 2001 to 2018 were evaluated. The MICs of ceftriaxone (CRO) and azithromycin (AZM) against the isolates were determined by the agar dilution method. N. gonorrhoeae isolates with AZM MICs of ≥1 μg/ml were identified...

    Yen-Hung Liu, Ya-Hui Wang, Chun-Hsing Liao, Po-Ren Hsueh
  • Impact of Species Diversity on the Design of RNA-Based Diagnostics for Antibiotic Resistance in <em>Neisseria gonorrhoeae</em>
    Susceptibility
    Impact of Species Diversity on the Design of RNA-Based Diagnostics for Antibiotic Resistance in Neisseria gonorrhoeae

    Quantitative assessment of antibiotic-responsive RNA transcripts holds promise for a rapid point-of-care (POC) diagnostic tool for antimicrobial susceptibility testing. These assays aim to distinguish susceptible and resistant isolates by transcriptional differences upon drug exposure. However, an often-overlooked dimension of designing these tests is that the genetic diversity within a species may yield differential transcriptional...

    Crista B. Wadsworth, Mohamad R. A. Sater, Roby P. Bhattacharyya, Yonatan H. Grad

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Back to top

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596